Showing results (521-530 of 1,648) with videos related to

Sort By:
Pageof 165
Hepatology International|July 24, 2015
Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinomaAndrew Yu-Keat Khor, Ying Toh, John Carson Allen, et al.
Hepatology International|July 24, 2015
Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxiaXia Ke, Yanke Chen, Pei Wang, et al.
Hepatology International|July 24, 2015
Pre-endurance training prevents acute alcoholic liver injury in rats through the regulation of damaged mitochondria accumulation and mitophagy balanceGuo-Dong Ma, Yan-Huan Liu, Qing-Lai Zhang, et al.
Hepatology International|July 24, 2015
Procalcitonin as a marker of sepsis in alcoholic hepatitisKundan Kumar, Samir Mohindra, Mithun Raj, et al.
Hepatology International|July 24, 2015
Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeksNghia H Nguyen, Shelley A McCormack, Brittany E Yee, et al.
Hepatology International|July 24, 2015
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis CShivakumar Narayanan, Kerry Townsend, Thomas Macharia, et al.
Hepatology International|July 24, 2015
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort studyMin Jae Kim, Kyoung-Ho Song, Nak-Hyun Kim, et al.
Hepatology International|July 21, 2016
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapyHiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, et al.
Hepatology International|April 23, 2020
Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patientsFai-Meng Sou, Tsung-Hui Hu, Chao-Hung Hung, et al.
Hepatology International|June 22, 2017
Noninvasive serum models to predict significant liver related events in chronic hepatitis CRagesh Babu Thandassery, Saad Al Kaabi, Madiha E Soofi, et al.
Pageof 165